🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Gaddii Guddaa › Ohio › Cincinnati

Qorannoo klinikaalii Dhibee Gaddii Guddaa Cincinnati, OH keessatti

Qorannoo 11 Dhibee Gaddii Guddaa f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07573176

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • University of Cincinnati Medical Center, Cincinnati
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05850689

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • University of Cincinnati, Cincinnati
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07227454

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Namoota walitti qabaa jiraSadarkaa 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06559306

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Vanda Investigational Site, Cincinnati
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06830044

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Namoota walitti qabaa jiraSadarkaa 3
  • Neurocrine Clinical Site, Mason · Miili 19 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06911112

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

Namoota walitti qabaa jiraSadarkaa 1/2
  • Lindner Center of Hope, Mason · Miili 19 fagaatti
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06795451

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Namoota walitti qabaa jiraSadarkaa 3
  • Clinical Research Site, Cincinnati
  • Clinical Research Site, Cincinnati
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07484217

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Namoota walitti qabaa jira
  • Cincinnati Childrens Hospital Medical Center, Cincinnati
Umuriin 14 hanga 18 · Saalaa hunda · Haaromfame 11-Gur-2026 · NCT07217444

Study of ALTO-300 in MDD

Namoota walitti qabaa jiraSadarkaa 2
  • Site 202, Cincinnati
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ado-2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Namoota walitti qabaa jiraSadarkaa 4
  • Clinical Research Site, Cincinnati
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 23-Ama-2025 · NCT06223880

Qorannoo Dhibee Gaddii Guddaa magaalota biroo keessatti

Qorannoo biroo Cincinnati keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.